Kuroda K, Kato TS, Amano A. Hypertensive cardiomyopathy: A clinical approach and literature review. World J Hypertens 2015; 5(2): 41-52 [DOI: 10.5494/wjh.v5.i2.41]
Corresponding Author of This Article
Tomoko S Kato, MD, PhD, FAHA, Department of Cardiovascular Surgery, Juntendo University, Heart Center, Building 9, 1F-Room124A, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan. rinnko@sannet.ne.jp
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hypertens. May 23, 2015; 5(2): 41-52 Published online May 23, 2015. doi: 10.5494/wjh.v5.i2.41
Hypertensive cardiomyopathy: A clinical approach and literature review
Kishio Kuroda, Tomoko S Kato, Atsushi Amano
Kishio Kuroda, Tomoko S Kato, Atsushi Amano, Department of Cardiovascular Surgery, Juntendo University, Bunkyo-ku, Tokyo 113-8431, Japan
Author contributions: Kuroda K and Kato TS contributed same amount to this work; all authors contributed to this work.
Conflict-of-interest: None of the authors has a financial relationship with a commercial entity that has an interest in the contents of the presented manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Tomoko S Kato, MD, PhD, FAHA, Department of Cardiovascular Surgery, Juntendo University, Heart Center, Building 9, 1F-Room124A, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan. rinnko@sannet.ne.jp
Telephone: +81-3-38133111 Fax: +81-3-38155228
Received: January 6, 2015 Peer-review started: January 7, 2015 First decision: March 6, 2015 Revised: March 23, 2015 Accepted: April 28, 2015 Article in press: May 2, 2015 Published online: May 23, 2015 Processing time: 134 Days and 22.4 Hours
Core Tip
Core tip: Hypertensive cardiomyopathy is a structural cardiac disorder generally accompanied by left ventricular hypertrophy associated with diastolic and/or systolic dysfunction in patients with persistent systemic hypertension, in the absence of other cardiac diseases. Because regression of myocardial hypertrophy is associated with a reduction in cardiovascular risk along with the improvement of cardiac function, timely diagnosis of the disease-specific pathophysiology and appropriate treatment strategy including maintaining optimal blood pressure control is very important in the care of patients with hypertension. In the present review manuscript, we have described the outline of hypertensive cardiomyopathy, pathophysiological feature of the disease, diagnosis and the treatment.
